Pediatric Pharm Flashcards
Neonate
< 4 weeks old
- premature: born before 37 weeks gestation
- term: born after 37 weeks
Infant
4 weeks - 1 year
Child
> 1 year but < 18 years
What two things affect drug mvmt from plasma to tissues?
CO and VRG
- peds have a higher CO going to VRG plus higher surface area
What organ is the primary determinant of biotransformation?
Liver
- high extraction ratio if drugs are flow dependent clearance (ie: propofol… if liver enzymes aren’t fully developed, drugs can accumulate)
- low extraction ratio drugs are enzyme activity dependent clearance (alfentanil and methadone)
What is the primary excretion organ?
- kidneys (renal CO x extraction ratio)
– Small, unbound drugs pass from plasma to GF
– Nonionized (uncharged) drug reabsorbed in tubules
– Ionized (charged) drug is excreted.
– GFR 30-40% adult for 34+weekers; 60% by 3rd week nml @6 mos.
t1/2 life elimination
- time for [] to fall 50%
- anesthesia drugs have multiple t1/2 b/c multiple compartments model
Oral Absorption
• Principle site of absorption is small intestine.
– Rate at which drug leaves the stomach determines speed of absorption.
• Rate of absorption is slower in neonates and young infants than in older children due to delayed gastric emptying.
– Matures through infancy and doesn’t reach adult rates until 6-8 months.
Rectal Absorption
- Absorption of drugs administered rectally is erratic and variable.
- Bioavailability of rectal acetaminophen in premature neonates and infants is variable.
– It is approximately 80% of oral dose and the rate of absorption is slower.
– Rectal bioavailability is formulation dependent and
decreases with age.
– Peak blood levels achieved at 60 to 180 minutes.
Intranasal
• Rich vascular plexus of the nasal cavity provides a direct route into the blood stream for medications that easily cross mucous membranes.
- For many IN medications the rates of absorption and plasma concentrations are comparable to intravenous administration, and are typically better than subcutaneous or intramuscular routes.
- Poor patient cooperation can be a factor in absorption
Transdermal/IM
• Increased cutaneous perfusion, thinner skin in neonates increases absorption of topically applied drugs in neonates.
– More tendency to form methemoglobin so use of EMLA in neonates need to be done cautiously.
- Skin thickness, perfusion, and hydration in infancy increases percutaneous absorption.
- IM in neonates/children is not altered.
Pulmonary Absorption
• Pulmonary absorption is more rapid in infants and children than adults.
• Increased respiratory rate and cardiac index.
• Greater proportional distribution of cardiac output to vessel rich organs.
• Anesthetic levels can become toxic more quickly than adults
• Congenital anomalies with right to left shunting can delay the FA/FI of inhalational anesthetics.
Distribution
• Children exhibit different drug distributions from adults due to
– different body composition
– altered protein binding
Baby Fat/H2O and distribution: implications for anesthesia drugs
- Water soluble drugs are more diluted and have lower receptor concentrations
- The loading dose must be increased in younger children to achieve effect
- Succinylcholine dose in infants up to 4mg/kg
- Less pronounced with lipid soluble drugs
Peds Drug Distribution
• Total body water is:
– 80-85% for premature infant
– 70-75% for term infants
– 50-60% adults
– 40% infants body weight is in ECF
– 20% adults body weight is ECF
– Vd H20 soluble drugs is >> in peds than adults
– Vd lipid soluble drugs is ??? In peds than adults
• Lower amounts of body muscle prolongs action of the drugs because?
– They can’t redistribute from site of action (Contact sensitive T 1/2 )